| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Domain | - | SEMA4D SEMA3D ANOS1 MYOM3 OSMR CAMTA1 CRLF2 BTN3A2 BTN3A1 ADGRA3 | 1.22e-05 | 663 | 52 | 10 | 2.60.40.10 |
| Domain | Ig-like_fold | SEMA4D SEMA3D ANOS1 MYOM3 OSMR CAMTA1 CRLF2 BTN3A2 BTN3A1 ADGRA3 | 2.10e-05 | 706 | 52 | 10 | IPR013783 |
| Domain | TRYPSIN_HIS | 1.93e-04 | 103 | 52 | 4 | IPR018114 | |
| Domain | TRYPSIN_SER | 2.15e-04 | 106 | 52 | 4 | PS00135 | |
| Domain | TRYPSIN_HIS | 2.23e-04 | 107 | 52 | 4 | PS00134 | |
| Domain | Peptidase_S1A | 2.75e-04 | 113 | 52 | 4 | IPR001314 | |
| Domain | TRYPSIN_DOM | 2.94e-04 | 115 | 52 | 4 | PS50240 | |
| Domain | Tryp_SPc | 3.14e-04 | 117 | 52 | 4 | SM00020 | |
| Domain | Trypsin | 3.57e-04 | 121 | 52 | 4 | PF00089 | |
| Domain | Trypsin_dom | 3.57e-04 | 121 | 52 | 4 | IPR001254 | |
| Domain | Peptidase_S1_PA | 3.80e-04 | 123 | 52 | 4 | IPR009003 | |
| Domain | - | 7.80e-04 | 15 | 52 | 2 | 3.30.70.960 | |
| Domain | IG | 1.07e-03 | 421 | 52 | 6 | SM00409 | |
| Domain | Ig_sub | 1.07e-03 | 421 | 52 | 6 | IPR003599 | |
| Domain | ZZ | 1.13e-03 | 18 | 52 | 2 | PF00569 | |
| Domain | ZF_ZZ_2 | 1.13e-03 | 18 | 52 | 2 | PS50135 | |
| Domain | ZF_ZZ_1 | 1.13e-03 | 18 | 52 | 2 | PS01357 | |
| Domain | Znf_ZZ | 1.26e-03 | 19 | 52 | 2 | IPR000433 | |
| Domain | ZnF_ZZ | 1.26e-03 | 19 | 52 | 2 | SM00291 | |
| Domain | Semaphorin | 1.40e-03 | 20 | 52 | 2 | IPR027231 | |
| Domain | SEA | 1.69e-03 | 22 | 52 | 2 | PF01390 | |
| Domain | FN3 | 1.74e-03 | 185 | 52 | 4 | SM00060 | |
| Domain | SPRY | 1.83e-03 | 87 | 52 | 3 | SM00449 | |
| Domain | SEA | 1.85e-03 | 23 | 52 | 2 | PS50024 | |
| Domain | SEA_dom | 1.85e-03 | 23 | 52 | 2 | IPR000082 | |
| Domain | TRYPSIN_SER | 2.02e-03 | 90 | 52 | 3 | IPR033116 | |
| Domain | FN3 | 2.27e-03 | 199 | 52 | 4 | PS50853 | |
| Domain | SPRY | 2.28e-03 | 94 | 52 | 3 | PF00622 | |
| Domain | SPRY_dom | 2.28e-03 | 94 | 52 | 3 | IPR003877 | |
| Domain | IG_LIKE | 2.34e-03 | 491 | 52 | 6 | PS50835 | |
| Domain | B30.2/SPRY | 2.35e-03 | 95 | 52 | 3 | IPR001870 | |
| Domain | B302_SPRY | 2.35e-03 | 95 | 52 | 3 | PS50188 | |
| Domain | Ig-like_dom | 2.64e-03 | 503 | 52 | 6 | IPR007110 | |
| Domain | FN3_dom | 2.71e-03 | 209 | 52 | 4 | IPR003961 | |
| Domain | Sema | 3.36e-03 | 31 | 52 | 2 | SM00630 | |
| Domain | Semap_dom | 3.36e-03 | 31 | 52 | 2 | IPR001627 | |
| Domain | Sema | 3.36e-03 | 31 | 52 | 2 | PF01403 | |
| Domain | SEMA | 3.36e-03 | 31 | 52 | 2 | PS51004 | |
| Domain | PSI | 3.57e-03 | 32 | 52 | 2 | PF01437 | |
| Domain | Plexin_repeat | 3.57e-03 | 32 | 52 | 2 | IPR002165 | |
| Domain | LRRCT | 3.57e-03 | 32 | 52 | 2 | PF01463 | |
| Domain | PSI | 6.67e-03 | 44 | 52 | 2 | IPR016201 | |
| Domain | Neurotransmitter_ion_chnl_CS | 6.97e-03 | 45 | 52 | 2 | IPR018000 | |
| Domain | Neur_chan_memb | 7.28e-03 | 46 | 52 | 2 | PF02932 | |
| Domain | PSI | 7.28e-03 | 46 | 52 | 2 | SM00423 | |
| Domain | Neur_chan_LBD | 7.59e-03 | 47 | 52 | 2 | PF02931 | |
| Domain | NEUROTR_ION_CHANNEL | 7.59e-03 | 47 | 52 | 2 | PS00236 | |
| Domain | Neurotrans-gated_channel_TM | 7.59e-03 | 47 | 52 | 2 | IPR006029 | |
| Domain | - | 7.59e-03 | 47 | 52 | 2 | 2.70.170.10 | |
| Domain | Neur_channel | 7.59e-03 | 47 | 52 | 2 | IPR006201 | |
| Domain | Neur_chan_lig-bd | 7.59e-03 | 47 | 52 | 2 | IPR006202 | |
| Domain | fn3 | 1.04e-02 | 162 | 52 | 3 | PF00041 | |
| Pubmed | Differential role for CD277 as a co-regulator of the immune signal in T and NK cells. | 2.37e-06 | 2 | 54 | 2 | 21918970 | |
| Pubmed | 2.37e-06 | 2 | 54 | 2 | 22846996 | ||
| Pubmed | 2.37e-06 | 2 | 54 | 2 | 21113407 | ||
| Pubmed | 7.09e-06 | 3 | 54 | 2 | 22767497 | ||
| Pubmed | Primate-specific BTN3A2 protects against SARS-CoV-2 infection by interacting with and reducing ACE2. | 1.42e-05 | 4 | 54 | 2 | 39142074 | |
| Pubmed | 1.42e-05 | 4 | 54 | 2 | 9382921 | ||
| Pubmed | 2.36e-05 | 5 | 54 | 2 | 29339503 | ||
| Pubmed | The cluster of BTN genes in the extended major histocompatibility complex. | 4.94e-05 | 7 | 54 | 2 | 11170752 | |
| Pubmed | 4.94e-05 | 7 | 54 | 2 | 24449837 | ||
| Pubmed | 6.59e-05 | 8 | 54 | 2 | 18701067 | ||
| Pubmed | 7.41e-05 | 52 | 54 | 3 | 26633812 | ||
| Pubmed | Common variants on chromosome 6p22.1 are associated with schizophrenia. | 1.29e-04 | 11 | 54 | 2 | 19571809 | |
| Pubmed | 1.55e-04 | 12 | 54 | 2 | 19812329 | ||
| Pubmed | Netrin1/DCC signaling promotes neuronal migration in the dorsal spinal cord. | 1.55e-04 | 12 | 54 | 2 | 27784329 | |
| Pubmed | 2.80e-04 | 16 | 54 | 2 | 22307612 | ||
| Pubmed | A 1.1-Mb transcript map of the hereditary hemochromatosis locus. | 3.56e-04 | 18 | 54 | 2 | 9149941 | |
| Pubmed | 3.78e-04 | 90 | 54 | 3 | 31280863 | ||
| Pubmed | 4.42e-04 | 20 | 54 | 2 | 22863734 | ||
| Pubmed | Activity-based E3 ligase profiling uncovers an E3 ligase with esterification activity. | 4.43e-04 | 95 | 54 | 3 | 29643511 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | 5.01e-04 | 1201 | 54 | 8 | 35696571 | |
| Pubmed | A semaphorin code defines subpopulations of spinal motor neurons during mouse development. | 6.39e-04 | 24 | 54 | 2 | 15869472 | |
| Pubmed | A single-cell time-lapse of mouse prenatal development from gastrula to birth. | 6.94e-04 | 25 | 54 | 2 | 38355799 | |
| Pubmed | TLR5 Supports Development of Placental Labyrinthine Zone in Mice. | 7.51e-04 | 26 | 54 | 2 | 34395439 | |
| Pubmed | 8.72e-04 | 28 | 54 | 2 | 18617019 | ||
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | 9.59e-04 | 736 | 54 | 6 | 29676528 | |
| Pubmed | 1.01e-03 | 126 | 54 | 3 | 16284245 | ||
| Pubmed | 1.05e-03 | 128 | 54 | 3 | 30995482 | ||
| Pubmed | Integration of repulsive guidance cues generates avascular zones that shape mammalian blood vessels. | 1.07e-03 | 31 | 54 | 2 | 22076636 | |
| Pubmed | The zinc-finger transcription factor GLI3 is a regulator of precerebellar neuronal migration. | 1.07e-03 | 31 | 54 | 2 | 30470704 | |
| Pubmed | 1.14e-03 | 32 | 54 | 2 | 22514301 | ||
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | 1.22e-03 | 1061 | 54 | 7 | 33845483 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | 1.54e-03 | 1105 | 54 | 7 | 35748872 | |
| Cytoband | 5q23.2 | 6.58e-04 | 32 | 54 | 2 | 5q23.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p36 | 1.23e-03 | 681 | 54 | 5 | chr1p36 | |
| GeneFamily | Fibronectin type III domain containing | 1.77e-05 | 160 | 37 | 5 | 555 | |
| GeneFamily | Butyrophilins|V-set domain containing|C2-set domain containing | 4.21e-04 | 15 | 37 | 2 | 458 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 6.11e-04 | 18 | 37 | 2 | 91 | |
| GeneFamily | Immunoglobulin like domain containing|Semaphorins | 7.56e-04 | 20 | 37 | 2 | 736 | |
| GeneFamily | Adenosine receptors|V-set domain containing | 4.46e-03 | 163 | 37 | 3 | 590 | |
| GeneFamily | Proteases, serine | 7.36e-03 | 63 | 37 | 2 | 738 | |
| ToppCell | 10x5'-Liver-Lymphocytic_Invariant-Inducer-like-ILC3|Liver / Manually curated celltypes from each tissue | 1.61e-06 | 163 | 54 | 5 | 7f61483eeb1fde21843c6391468e13cb0cc2a89f | |
| ToppCell | BAL-Mild-Myeloid-cDC-cDC-cDC_10|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.62e-06 | 180 | 54 | 5 | 32d871738a24071b70084a7e80148a516110c78b | |
| ToppCell | BAL-Mild-Myeloid-cDC-cDC-cDC_10|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.62e-06 | 180 | 54 | 5 | 067ca8a15228c7f3b3bc7aecbc9b1611ca05e176 | |
| ToppCell | facs-Liver-Hepatocytes-24m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.84e-06 | 183 | 54 | 5 | d0721c6aa426953a520d40e976b6e65aa7ca65e8 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.77e-06 | 194 | 54 | 5 | 5d0b0d8e96f0e0297a4dba70a05d87081a4eb323 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.77e-06 | 194 | 54 | 5 | 6ac759828c41ffa974ee82842162caa959351dd1 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Granulocytic-Neutrophil-Neu_c2-CXCR4(low)|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.72e-05 | 127 | 54 | 4 | 353484362448f27e8377447d0c26391b1da7acc5 | |
| ToppCell | 343B-Myeloid-Macrophage-SPP1+_Macrophage_3|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 3.75e-05 | 155 | 54 | 4 | c4dc0fa1d0e657753a56939eb4829fb60382c17f | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Epithelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.04e-05 | 158 | 54 | 4 | 9f58428f70d1427b20122c5c1cc7bf521d0f4832 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Epithelial-Hepatocyte_(Pericentral)|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.24e-05 | 160 | 54 | 4 | c42bcc6c7d113f0db43febb088b75ca4ac7cb7a3 | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.45e-05 | 162 | 54 | 4 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | facs-Lung-Endomucin-24m-Epithelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.89e-05 | 166 | 54 | 4 | 64a0762eb9cafb6a079df296ed677c8e0ae0efa7 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Epithelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.13e-05 | 168 | 54 | 4 | b98af4043dfa5dfa4413e482879fad88de484675 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Epithelial-hepatocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.13e-05 | 168 | 54 | 4 | 073b53d4cee6bc8c5c6fce51cf6cd9c316478f69 | |
| ToppCell | BAL-Mild-Myeloid-cDC-cDC-cDC_11|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.25e-05 | 169 | 54 | 4 | e3410ccb3f85811c75694e286115803911169a2f | |
| ToppCell | droplet-Liver-HEPATOCYTES|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.25e-05 | 169 | 54 | 4 | f195467438c589f87224bde7da720dea072d110c | |
| ToppCell | BAL-Mild-Myeloid-cDC-cDC-cDC_11|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.25e-05 | 169 | 54 | 4 | a4f610d07c3ba5537f4497f523669b914f7eddc1 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.25e-05 | 169 | 54 | 4 | 7785cab967a33560830c394c918d6ce625103858 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.49e-05 | 171 | 54 | 4 | eddc5e05003382603ee49f74b9e2242a43021096 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.75e-05 | 173 | 54 | 4 | f612d4ea9ab8dcde475f4118bca3e49be786e7fa | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.75e-05 | 173 | 54 | 4 | c62e3ffed55bbb00dcaef6da0aab8446f3f55085 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Epithelial-Hepatocyte_(Periportal)|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.01e-05 | 175 | 54 | 4 | 5c38d4b6c03473d841e6203a7efaa6dcb2d59386 | |
| ToppCell | Club_cells-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 6.14e-05 | 176 | 54 | 4 | 88c4ed0ab4a4ede8cad21385d799b723b5786cd9 | |
| ToppCell | Control-Epithelial_alveolar-AT_1-Differentiating_AT1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.28e-05 | 177 | 54 | 4 | 9af14a056eb6d88c6f11b09f6d4c0d3448d647d5 | |
| ToppCell | TCGA-Head_and_Esophagus-Primary_Tumor-Head_and_Neck_Carcinoma-Squamous_Cell_Carcinoma-4|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9 | 6.70e-05 | 180 | 54 | 4 | 886ebaf9cf8992e8dd13fca799a1d1a2a9ce73d8 | |
| ToppCell | 10x5'-Lung-Myeloid_Dendritic-migDC|Lung / Manually curated celltypes from each tissue | 6.70e-05 | 180 | 54 | 4 | e9e8992deb0beeee5548910e4616e7c990763d99 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.85e-05 | 181 | 54 | 4 | bd7e9437839bca543ca5945df43d6525e6a312a8 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.85e-05 | 181 | 54 | 4 | b45b11428d13950369347e051d4d517efb2bd4fd | |
| ToppCell | facs-Liver-Hepatocytes-24m-Epithelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.00e-05 | 182 | 54 | 4 | 770ce9f3f4538d0181a0181543841bc964c68274 | |
| ToppCell | facs-Liver-Hepatocytes-24m-Epithelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.00e-05 | 182 | 54 | 4 | 77ab860e2add49dad0c1ffbfc64278ad499dfbd5 | |
| ToppCell | facs-Liver-Hepatocytes-24m-Epithelial-hepatocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.00e-05 | 182 | 54 | 4 | 4921c7d5687cc79f896b39753bb621d7e3d2972f | |
| ToppCell | droplet-Lung-21m-Epithelial-airway_epithelial-club_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.30e-05 | 184 | 54 | 4 | 9365cdc52a2419e3f27e1c1c9310fa707d1e506b | |
| ToppCell | droplet-Lung-21m-Epithelial-airway_epithelial-club_cell-club_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.30e-05 | 184 | 54 | 4 | 204d16c48f822c98dc4118ac97a4f99f7e1163c8 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.30e-05 | 184 | 54 | 4 | 57c792e6e2fedba25d3350ffe649fd74750b579d | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_FAM150B|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.30e-05 | 184 | 54 | 4 | 7d41784eac0935e77d6bc701f20c693adf998730 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.30e-05 | 184 | 54 | 4 | d7bd0f0c607bade67c99e9fb3578a570298bf926 | |
| ToppCell | droplet-Lung-nan-21m-Epithelial-club_cell_of_bronchiole|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.30e-05 | 184 | 54 | 4 | 7cc3b9bba1f600b40b02fe2456b5d007dbf9fa37 | |
| ToppCell | droplet-Lung-nan-21m-Epithelial-Club_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.30e-05 | 184 | 54 | 4 | 53b71c4ac86dc5e42763b8f64fbc917177531017 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.61e-05 | 186 | 54 | 4 | 3aebe163799109ffc67e4e10ee47c2dd0886a92c | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.77e-05 | 187 | 54 | 4 | 4ae7465174e0295d2c3b614b321a3b2f514dd22a | |
| ToppCell | Mild-Myeloid-mDC-|Mild / Condition, Lineage, Cell class and cell subclass | 8.60e-05 | 192 | 54 | 4 | 8520b3fdf4508ac66f7918da613abc928ab5832a | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.60e-05 | 192 | 54 | 4 | f6ec683b2133b3095a1fcc06ca8605cf38f774b5 | |
| ToppCell | Mild-Myeloid-mDC|Mild / Condition, Lineage, Cell class and cell subclass | 8.60e-05 | 192 | 54 | 4 | da3952bd5c96242c15eb76678d0608ae2926a16e | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_10|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 8.60e-05 | 192 | 54 | 4 | 2c69f3f388b69fb1c1968c923cdbab90658883dd | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.60e-05 | 192 | 54 | 4 | 690b3d17c481159bc96b8bc7f6a66b51343ee858 | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_10|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.60e-05 | 192 | 54 | 4 | d5a7b546ebfb2e757dd9c64cb1b651f6ed0e0fc7 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.60e-05 | 192 | 54 | 4 | bf1943715085c4124b1675888b0615c9500ec888 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_10|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 8.78e-05 | 193 | 54 | 4 | a2194012dfa0174c6160900625c44e0fd04c50e7 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.78e-05 | 193 | 54 | 4 | 294cb5b580bb83fe0eb04f112d5507aac35d4d44 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-T_lymphocytic-CD8-positive,_alpha-beta_T_cell|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.78e-05 | 193 | 54 | 4 | a594f89a18273797506287d9e22f72abe53e4920 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_10|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.78e-05 | 193 | 54 | 4 | 7426a30ed01e5c8376b3e0ebe0f1057cfee88340 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.78e-05 | 193 | 54 | 4 | 3d3c45d5ff6f3396a1990615aae9fe176e799994 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_9|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 8.78e-05 | 193 | 54 | 4 | 7842f29c16fe3a289ed3861fa570430142d2363f | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.95e-05 | 194 | 54 | 4 | 02a9cc821c2b14aa7d0e55661a5fab66364474e1 | |
| ToppCell | BAL-Mild-Myeloid-cDC|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.13e-05 | 195 | 54 | 4 | 9e5cf33b5dd455efa464a63d7116786c0786aefd | |
| ToppCell | BAL-Mild-Myeloid-cDC|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.13e-05 | 195 | 54 | 4 | 6ba23e19801305e071b0e4aaf1ee6f53f3b027d3 | |
| ToppCell | Mild_COVID-19-Myeloid-cDC|Mild_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 9.13e-05 | 195 | 54 | 4 | 24149bb6933135b1a0a5c7f505914942b3782c3a | |
| ToppCell | BAL-Mild-Myeloid-cDC-cDC|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.13e-05 | 195 | 54 | 4 | 66e5fd9f3208a06d617c5e994822bf57dceae7e2 | |
| ToppCell | BAL-Mild-Myeloid-cDC-cDC|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.13e-05 | 195 | 54 | 4 | 7209babdff96c93cd52cfe5d5cfd7e3c0274d8dd | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.32e-05 | 196 | 54 | 4 | 7af6c5147ac859353504d19727dbe24f63a29dd4 | |
| ToppCell | droplet-Heart-nan-18m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.32e-05 | 196 | 54 | 4 | e386526332138e636aef2542c11316347a45689c | |
| ToppCell | LPS_IL1RA_TNF|World / Treatment groups by lineage, cell group, cell type | 9.50e-05 | 197 | 54 | 4 | 0a6550dce156fc81f15b1e7830d331ca50d87d06 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 9.50e-05 | 197 | 54 | 4 | b94645d57efe8d9e032bffb8c89af1f425c6421e | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.50e-05 | 197 | 54 | 4 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-AT1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 9.69e-05 | 198 | 54 | 4 | 5a85c286f79cde5811d2595a3397c6fb7685adee | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Club|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.69e-05 | 198 | 54 | 4 | 1408e02e053ad3406229bfe8189da03be6366e81 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.69e-05 | 198 | 54 | 4 | af399569c718f5fd971d73a7926768c9311002a3 | |
| ToppCell | COVID-19-Myeloid-Migratory_DC|Myeloid / Condition, Lineage and Cell class | 9.69e-05 | 198 | 54 | 4 | 90f3b227cbc61c268d6d94bc9945a08d83d2d3d5 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.88e-05 | 199 | 54 | 4 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 9.88e-05 | 199 | 54 | 4 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 9.88e-05 | 199 | 54 | 4 | d43c605a4ff221cf78d91678c15d2ad20f831c7f | |
| ToppCell | Parenchymal-10x3prime_v2-Epithelial-Epi_airway_basal|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 9.88e-05 | 199 | 54 | 4 | 995d710d7302272e7951a5a5d766d1039089ee2b | |
| ToppCell | Parenchymal-10x3prime_v2-Epithelial-Epi_airway_basal-Basal|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 9.88e-05 | 199 | 54 | 4 | e9c47f565a0a7737ecff68569d668aeb707ae5a6 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-CALB1--L1-3|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.01e-04 | 200 | 54 | 4 | f3c710f0fc8a7bfb5371d1aff6e3d8f266953153 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-CALB1|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.01e-04 | 200 | 54 | 4 | 1639982d9d994918f7912d12d9d7cfcbc9da4145 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-LGR5--L5-6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.01e-04 | 200 | 54 | 4 | 8c1d4fffa5abe89ee2ff84fed2dfa97c779bde04 | |
| ToppCell | Neuronal-Inhibitory|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.01e-04 | 200 | 54 | 4 | 9ff8647e2de0b538e15929dca88ebb20ff7ab043 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-LGR5-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.01e-04 | 200 | 54 | 4 | 1026b4ede4ea61d01ea942164b37a08c8c8234ff | |
| ToppCell | distal-2-Epithelial-Alveolar_Epithelial_Type_1|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.01e-04 | 200 | 54 | 4 | 313ec1e53bd738a9cb48dc5b946261156f99f44b | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-T-T_CD8-CD8_GZMK+|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.01e-04 | 200 | 54 | 4 | 510d84bf7a4621b079e5a7330d25e04508c84a49 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-NMBR-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.01e-04 | 200 | 54 | 4 | d416a7be1a4e6232fb58a9687774da24821f1fdd | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-CALB1-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.01e-04 | 200 | 54 | 4 | 70a06fd7fb8de2c8ec3e3182e4476ced049daeae | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-NMBR|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.01e-04 | 200 | 54 | 4 | 862db57d043bdf3cb059fbfc8b29bc1eafdf64ec | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.01e-04 | 200 | 54 | 4 | 8683445ad5b70748c4a1f12eb77d47623085147e | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-NMBR--L1|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.01e-04 | 200 | 54 | 4 | a91345f268f13170c27309333603eb82400c9947 | |
| ToppCell | MS-Multiple_Sclerosis-Lymphocyte-T/NK-ILC|Multiple_Sclerosis / Disease, condition lineage and cell class | 1.01e-04 | 200 | 54 | 4 | ab9bdc9365cbdffe4ed246ce0c8a008a390e387e | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-LGR5|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.01e-04 | 200 | 54 | 4 | 72c9cd872074b60f62685a95eab83c41e609eb6e | |
| Computational | Neighborhood of CASP8 | 3.97e-05 | 27 | 27 | 3 | GNF2_CASP8 | |
| Computational | Neighborhood of SNRK | 4.44e-05 | 28 | 27 | 3 | GNF2_SNRK | |
| Computational | Neighborhood of ITGAL | 3.40e-04 | 55 | 27 | 3 | GNF2_ITGAL | |
| Disease | bipolar disorder | 5.79e-05 | 577 | 51 | 7 | MONDO_0004985 | |
| Disease | dipeptidase 2 measurement | 1.31e-04 | 10 | 51 | 2 | EFO_0801528 | |
| Disease | persulfide dioxygenase ETHE1, mitochondrial measurement | 1.91e-04 | 12 | 51 | 2 | EFO_0008258 | |
| Disease | muscular dystrophy (implicated_via_orthology) | 6.02e-04 | 21 | 51 | 2 | DOID:9884 (implicated_via_orthology) | |
| Disease | Visual seizure | 7.19e-04 | 101 | 51 | 3 | C0270824 | |
| Disease | Epileptic drop attack | 7.19e-04 | 101 | 51 | 3 | C0270846 | |
| Disease | Generalized seizures | 7.19e-04 | 101 | 51 | 3 | C0234533 | |
| Disease | Clonic Seizures | 7.19e-04 | 101 | 51 | 3 | C0234535 | |
| Disease | Vertiginous seizure | 7.19e-04 | 101 | 51 | 3 | C0422855 | |
| Disease | Gustatory seizure | 7.19e-04 | 101 | 51 | 3 | C0422854 | |
| Disease | Seizures, Somatosensory | 7.19e-04 | 101 | 51 | 3 | C0422850 | |
| Disease | Olfactory seizure | 7.19e-04 | 101 | 51 | 3 | C0422853 | |
| Disease | Seizures, Auditory | 7.19e-04 | 101 | 51 | 3 | C0422852 | |
| Disease | Generalized Absence Seizures | 7.19e-04 | 101 | 51 | 3 | C4505436 | |
| Disease | Convulsive Seizures | 7.19e-04 | 101 | 51 | 3 | C0751494 | |
| Disease | Seizures, Sensory | 7.19e-04 | 101 | 51 | 3 | C0751496 | |
| Disease | Jacksonian Seizure | 7.19e-04 | 101 | 51 | 3 | C0022333 | |
| Disease | Non-epileptic convulsion | 7.19e-04 | 101 | 51 | 3 | C0751056 | |
| Disease | Atonic Absence Seizures | 7.19e-04 | 101 | 51 | 3 | C0751123 | |
| Disease | Complex partial seizures | 7.19e-04 | 101 | 51 | 3 | C0149958 | |
| Disease | Single Seizure | 7.19e-04 | 101 | 51 | 3 | C0751110 | |
| Disease | Epileptic Seizures | 7.19e-04 | 101 | 51 | 3 | C4317109 | |
| Disease | Nonepileptic Seizures | 7.19e-04 | 101 | 51 | 3 | C3495874 | |
| Disease | Tonic Seizures | 7.40e-04 | 102 | 51 | 3 | C0270844 | |
| Disease | Absence Seizures | 7.40e-04 | 102 | 51 | 3 | C4316903 | |
| Disease | Convulsions | 7.40e-04 | 102 | 51 | 3 | C4048158 | |
| Disease | Seizures, Focal | 7.83e-04 | 104 | 51 | 3 | C0751495 | |
| Disease | Myoclonic Seizures | 7.83e-04 | 104 | 51 | 3 | C4317123 | |
| Disease | Tonic - clonic seizures | 7.83e-04 | 104 | 51 | 3 | C0494475 | |
| Disease | lung carcinoma | 1.44e-03 | 482 | 51 | 5 | EFO_0001071 | |
| Disease | liver iron measurement | 1.49e-03 | 33 | 51 | 2 | EFO_0010056 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VYTRVSKFSTWINQV | 246 | P40313 | |
| WNSKDLYIGVSTVQV | 1321 | Q9Y6Y1 | |
| TRSIHVKSGVWVAYQ | 2606 | Q68DQ2 | |
| KWVSSSLRQVVNVYA | 66 | O00481 | |
| NLAVSQVTTKYVLWV | 341 | Q00973 | |
| LWVGVTARNIYKQVT | 841 | Q8IWK6 | |
| IVVKSYRPAQVTWSQ | 251 | Q5VV41 | |
| QVRTWVKQYRASETS | 421 | Q6JQN1 | |
| WKFTVNIISVYKQGT | 511 | O95631 | |
| TSNVIWVGNYSTTVK | 76 | Q99650 | |
| NTSSVQLVKSWYIQS | 81 | Q16654 | |
| AITYWGQTRLKSAKV | 376 | P23352 | |
| VITWIVTQVAISYTV | 416 | Q6ZWT7 | |
| TIRVWNVTKKQYSLQ | 3451 | Q15751 | |
| SRYVLKAGQTVTIWA | 486 | P20700 | |
| QYSLFKVTRASSQWV | 186 | Q9UGM5 | |
| QSSVTTIVKSYYWRV | 371 | Q9P1W3 | |
| VVYVWTNGSTKSVVV | 201 | P31644 | |
| TIKGTTAYVPQQSWI | 696 | Q92887 | |
| TVQVTWNASKYSRTN | 41 | Q9HC73 | |
| TVYVWNRSSLKTINV | 931 | Q9UMZ3 | |
| TSTKTVIRYNGTVTW | 146 | P30532 | |
| SVYSWDIVVQRVGSK | 261 | O15371 | |
| WQIETKYSTKVLTGN | 16 | Q8N1D5 | |
| SGVNKYSTVLSRIWL | 11 | Q9NTQ9 | |
| SNKWTISSIQSRVLY | 581 | Q5VVM6 | |
| QPWKIYSRKTTTQSL | 531 | Q96GE4 | |
| KWVSSSLRQVVNVYA | 66 | P78410 | |
| LTDTQVKTWYQNRRT | 271 | Q9NY43 | |
| TFYTNVWKIESQRNV | 241 | P03952 | |
| SIVTVAEQKYQSTLW | 401 | Q9NX74 | |
| TVVVQWDQGTRTNYR | 51 | Q96AX9 | |
| TQWGRILSSYVLKTV | 396 | Q3MIP1 | |
| VGKTTLARYITQAWK | 41 | Q5TCS8 | |
| IKTWVQTRLGDYQTQ | 1091 | P46939 | |
| RIQQVYKTKTRSSGW | 121 | Q05952 | |
| FVVTNQTTWTGRQLV | 456 | Q504Y2 | |
| TLSKVQQVLSWSYGE | 176 | Q3MII6 | |
| EWYLKTRQSVQQFTV | 41 | Q8NA58 | |
| QVYWLTISSNGVLKR | 1606 | Q9UKZ4 | |
| TTVEQSHTKWVRYNG | 346 | Q92854 | |
| SSWVGTTQIVKITYK | 176 | A4IF30 | |
| GSWNYKLNTISTEVV | 46 | Q5VX52 | |
| TTVWYFSISNVKLQG | 271 | Q15399 | |
| KSQQATIKWYIQRSG | 616 | O95025 | |
| TSWVNSSNYKVVLLG | 56 | Q7Z460 | |
| TRVTSYRNWITSKTG | 401 | Q86T26 | |
| LWTVQRQYGVSVTKT | 671 | Q9H5L6 | |
| NRVRKWNVTTTNYGK | 176 | Q5XPI4 | |
| VVNVTWRNKTYVGTL | 391 | Q9ULD9 | |
| TLKIFTYINSWTQRQ | 31 | Q70CQ2 | |
| KSWAIEIGYQTRQVS | 291 | Q9C0I4 | |
| YTRITGVISWIQQVV | 796 | Q8IU80 | |
| YSRKVGTSEWQTVNN | 636 | Q5VTT5 |